ArticleCancers2026
Health-Related Quality of Life Among People Diagnosed with High-Risk Non-Muscle Invasive Bladder: Baseline Data from the ANZUP BCG + Mitomycin Clinical Trial.
Kathryn Schubach et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.